A B S T R A C T After the inoculation of Golden Syrian hamsters with the TC-83 vaccine strain of Venezuelan encephalitis (VE) virus, a sustained diminution in glucose-stimulated insulin release and glucose intolerance of shorter duration develops. To understand better the mechanism of this defect in insulin release, we examined insulin secretion in response to several test agents in isolated perifused islets from control and 24-d post-VE virus-infected hamsters. 50 islets were used in all perifusion experiments, and data were expressed as total insulin released as well as peak response for each test agent during a 30-min perifusion period from control and VE-infected islets. After perifusion with 20 mM glucose, a 45% diminution of insulin release was noted in VE-infected islets in comparison with control islets, which in turn was similar to in vivo findings. However, following 1-mM tolbutamide stimulation, insulin release was similar in control and VE-infected islets. In separate studies, 1 mM tolbutamide, 10 mM theophilline, 1 mM dibutyryl cyclic (c)AMP, and 1 mM 8-bromo-cAMP resulted in statistically similar insulin-release curves in control and VE-infected islets. Additional experiments assessing [5_3H]glucose use in control and infected islets after 20 min ofperifusion with 20 mM glucose revealed virtually identical values (239±30-control; and 222 ±27-VE-infected islets). Morphological and morphometric evaluation of VE-infected islets (21 d following virus inoculation) showed no changes in islet volume density, beta cell density, and beta cell granulation. Thus, VE virus induces a defect in glucose-stimulated insulin release from hamster beta cells that can be corrected by cAMP analogues and does not alter islet glucose use.
INTRODUCTION
A diabetes mellitus-like syndrome has been reported in genetically susceptible mice inoculated with either the M variant of encephalomyocarditis (EMC) virus (1, 2) or a diabetogenic variant of coxsackie B4 virus (3) . In both of these systems, a rapid lysis of beta cells occurs with the severity of hyperglycemia closely correlating with the degree of virus-induced beta cell destruction (3, 4) . Another example of virusinduced alterations of carbohydrate metabolism occurs after inoculation of Golden Syrian hamsters with the TC-83 vaccine strain of Venezuelan encephalitis (VE) virus (5) . After TC-83 VE infection, there is a 20% mortality rate with surviving animals exhibiting a 24-d period of glucose intolerance and a severe diminution of glucose-stimulated insulin release for the 3-mo duration of study (5) . This model differs from the EMC and Coxsackie B4 systems in that VE is an enveloped virus in which viral proteins become incorporated in membranes of host tissue (6, 7) . Although some cell lysis occurs following VE infection, long-term pathologic changes in the pancreas do not develop (5) . To understand the mechanism for this virus-induced inhibition of glucose-stimulated insulin release at a more basic level, we performed a series of experiments using isolated perifused hamster islets obtained from virus-infected and control animals. The results suggest that there is a virus-induced defect, possibly at the level of the beta cell membrane, but that events distal to the cyclic (c)AMP system of the beta cell are intact. (17) of the unlabeled antibody-enzyme method of Stemberger et al. (18) . Primary antisera against insulin and pancreatic glucagon for these studies were raised in rabbits. Sheep anti-rabbit gammaglobulin was obtained from Antibodies, Inc., Davis, Calif., peroxidase-antiperoxidase antiserum was purchased from N. L. Capell Laboratories, Inc., Cochranville, Pa., and diaminobenzidine-tetraHCl was obtained from Aldrich Chemical Co. The islet volume density within the pancreas was determined by a linear scanning method (19) . At least 1,000 mm of total scan was made over each pancreas.
METHODS
The volume densities of beta and alpha cells within the islet were estimated by the point count method (20 Effects of 20 mM glucose on insulin secretion. In Fig. 1 , the effect of 20 mM glucose, a near maximal stimulatory dose for insulin release (22) , is depicted in relation to insulin secretion from islets obtained from hamsters 24 (24) , to inhibit cAMP phosphodiesterase (25, 26) , and to increase intraislet cAMP content in the rat (2, 3). 1 min after 1-mM tolbutamide administration, there was a prompt rise in insulin response with a peak response occurring at 3 min in both control and TC-83 VE-infected islets with virtually identical secretory profiles in both groups (Fig. 3) Effects of theophilline on insulin secretion. Theophilline was used to assess its ability to correct the decrease in glucose-stimulated insulin release observed with tolbutamide because both agents are phosphodiesterase inhibitors and elevate islet cAMP (23, (27) (28) (29) (30) . Fig. 4 shows that at the outset of this protocol, the TC-83 VE-infected islets demonstrated the expected significantly decreased insulin response to 20 mM glucose and that the combination of 10 mM theophilline and 20 mM glucose completely corrected the insulin response to that noted in control islets.
Effects of dibutyryl cAMP on insulin secretion. Because the phosphodiesterase inhibitors (tolbutamide and theophilline) corrected the decreased insulin secretion in combination with 20 mM glucose, a cAMP analogue was next used in an effort to augment insulin secretion (Fig. 5 ). 2 mM butyric acid was used as a control to show that the cAMP moiety and not the butyrate moiety results in correction in the dimninished insulin release observed with 20 mM glucose alone (31) . Butyrate is also a fatty acid that has been reported to stimulate insulin secretion in vitro (32, 33) . In these experiments, control islets released a similar amount of insulin when perifused with 20 mM glucose alone or the combination of 20 mM glucose and 2 mM butyric acid. Likewise, the amount of insulin released by VE-infected islets when perifused with 20 mM glucose alone or the combination of20 mM glucose and 2 mM butyric acid was not significantly different. Insulin secretion was comparable in control and VEinfected islets that were perifused with 20 mM glucose and 2 mM butyric acid. This observation suggests that the regulation of insulin secretion by shortchain fatty acids in the presence of high glucose is intact in VE-infected islets. The combination of 20 mM glucose and 1 mM dibutyryl cAMP on insulin secretion resulted in a two-to threefold increase of insulin values in control and VE-infected islets when compared with respective insulin release areas in the presence of 20 mM glucose and 2 mM butyric acid. Therefore, the cAMP moiety of the cyclic nucleotide analogue clearly corrects the beta cell defect in virusinfected islets.
Effect of 8-bromo-cAMP on insulin secretion.
The effect of another cAMP analogue, 8-bromo-cAMP, was assessed in control and virus-infected islets. As is noted in Fig. 6 , the combination of 1 mM 8-bromocAMP and 20 mM glucose completely corrected the reduced insulin response that occurred with 20 mM glucose alone. Metabolic studies of 3H20 formation from [5-3H]-glucose. Under certain circumstances, e.g., with the absence of Ca2+ in the perifusate, the insulin-releasing function of glucose can be dissociated from the ability of islets to utilize glucose (34) . Accordingly, the relationship between insulin release from TC-83 VE-infected islets in response to 20 mM glucose (20-min time point) and the sequential assessment of glucose use in the same islets was determined (Table  I) . There was no significant difference in the ability of control and virus-infected islets to metabolize glucose to CO2 and 3H20.
Morphologic and morphometric studies. no significant morphological differences between the control and virus-infected islets 3 wk after TC-83 VE inoculation. Assessment of beta cell granulation showed degranulation 3 d after VE infection. In contrast, 21 d postvirus inoculation, beta cell granulation was normal (Cf. Fig. 7a, b) . Morphometric analysis of control and virus-infected pancreas 3 and 21 d postinfection confirmed the subjective impression. Furthermore, the DNA content of 50 control and infected islets was virtually identical (data not shown). (1) (2) (3) (4) (5) 35) . In the case of infection with both Coxsackie B4 virus and the M variant of EMC virus in genetically susceptible mice, an acute diabeteslike syndrome develops within 7 d. The severity of hyperglycemia correlates closely pathologically with the degree of pancreatic damage (4). This acute model of virusinduced diabetes is not applicable to all cases of human, juvenile-onset diabetes, some of which may take months to years to develop after infection. In fact, a 10-20-yr period may elapse between congenital rubella infection and the onset of diabetes mellitus (36) . In addition, multiple viral infections may be involved in the clinical expression of disease (35) . For these reasons, the finding that the TC-83 vaccine strain of VE virus infection in Golden Syrian hamsters causes a transient glucose intolerance with sustained diminution of glucose-stimulated insulin release and no long-term morphologic abnormalities (5) provided an attractive additional model of virusislet cell interaction. In the present investigations, we used isolated hamster islets in a perifusion system with microchambers to study the mechanism of the decrease in glucose-stimulated insulin release after VE infection. This in vitro system provided an accurate assessment of insulin secretion without the influence of neural and hormonal factors that are present in vivo. The elimination of neural factors is particularly relevant because the TC-83 vaccine strain of VE is a pantropic virus that localizes not only in hamster pancreas (5), but also in brain [Purkinje cells, vascular, and olfactory systems (37, 38) ]. It should also be noted that the morphologic results showed that beta cell granulation, total islet volume density, beta cell volume density, and DNA per islet were not significantly different in control and VE-infected islets 21 d after virus inoculation. However, the insulin secretion data were calculated with respect to DNA content of islets as an added precaution to correct for possible virus-related difference in size that might cause spuriously low secretion profiles in 21-24-d post infection islets.
Virus-induced Alterations in Insulin Release
Interestingly, similar to the in vivo hamster data (5), there was a 45% decrease in insulin secretion in response to 20 mM glucose in the perifusion system; yet these animals did not exhibit nonfasting hyperglycemia in vivo. Furthermore, the profound decrease in insulin seretion during glucose administration persisted in islets obtained 8 mo after VE inoculation, and these hamsters were also not hyperglycemic. The presence of hypoinsulinemia in response to glucose in the absence of elevated plasma glucose levels would be compatible with increased peripheral sensitivity to insulin in vivo. Certainly, diphenylhydantoin and other agents are known to decrease insulin levels after glucose administration without impairing glucose tolerance in individuals not genetically predisposed to diabetes (39) . This latter observation supports the notion that a larger amount of insulin is released in response to secretagogues than is really necessary for biologic effect.
One possible mechanism by which VE virus could lead to abnormalities in insulin release after glucose, without causing morphologic abnormalities, would be a virus-related defect at the level of the beta cell membrane. VE belongs to a group of enveloped viruses that have a lipoglycoprotein coat with lipid derived totally from host and proteins although glycosylated by host which the insulin release in VE-infected islets is markedly decreased following 20 min of20 mM glucose without any change in the ability of the islets to utilize glucose. There is a precedent for this dissociation. The elimination of calcium from the perifusion medium of mouse pancreatic islets does not alter the rate of glucose oxidation, but decreases glucose-stimulated insulin release (34) .
Further efforts to elucidate the changes in insulin secretion in vitro in perifused hamster islets following VE-infection focused on the cAMP system of the islets. Tolbutamide and theophylline, both of which inhibit phosphodiesterase, were able to correct the decrease in insulin release when the agent was added to 20 mM glucose in the perifusion system. The derivatives, dibutyryl cAMP and 8-bromo-cAMP, were also able to correct the diminished insulin response to glucose when added in combination with 20 mM glucose to the perifusion buffer. Therefore, the data are consistent with normal beta cell function distal to the cAMP system.
Because glucose-induced insulin release is decreased but can be normalized by certain cAMP analogues in VE-infected islets, it is reasonable to believe that a virus-induced alteration exists between the beta cell membrane and cAMP itself. It is thought that the relationship of glucose and cAMP to insulin release is in part a function of the ability of cAMP to inhibit the uptake ofcytosolic calcium into intracellular organelles (44, 45) . Cytosolic calcium is therefore raised and stimulates insulin release when the rate of calcium efflux across the cell membrane is reduced by glucose (44, 45) . In this regard, it is noteworthy that Schubart et al. (46) recently demonstrated the presence of Ca++-calmodulin-dependent protein kinase activity in a hamster insulinoma cell line. In this line, similar to the VE-infected islet model, insulin is not released appropriately in response to an elevation in glucose concentration (47) . These workers also presented evidence that calmodulin may regulate Ca++-mediated insulin release in these insulinoma cells (46) . Thus, following TC-83 VE infection, it is possible that an abnormality exists in beta cell membrane adenylate cyclase, calmodulin, and/or islet cAMP generation any of which could contribute to the abnormalities in insulin release observed in this system.
In conclusion, our studies show the feasibility of using a perifusion system to assess subtle alterations in beta cell function after infection with VE virus. This virus induces a defect in glucose-stimulated insulin release from hamster beta cells despite no abnormalities in glucose oxidation. Insulin response to phosphodiesterase inhibitors and cAMP analogues in the high glucose experiments are consistent with normal beta cell function distal to the cAMP system. Further studies will be required to determine the precise locus of the lesion.
